Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines
- UCLA School of Medicine, CA (United States)
- Clinical Genetics Center, La Mirada, CA (United States)
- National Center for Human Genome Research, Bethesda, MD (United States)
- Univ. of Texas Southwestern Medical Center, Dallas, TX (United States)
Molecular genetic studies on HeLa cell-derived nontumorigenic and tumorigenic hybrids have previously localized the HeLa cell tumor-suppressor gene to the long arm of chromosome 11. Extensive molecular and cytogenetic studies on HeLa cells have shown chromosome band 11q13 to be rearranged in this cell line. To determine whether q13 rearrangement is a nonrandom event in cervical carcinomas, six different human papilloma virus (HPV)-positive (HeLa, SiHa, Caski, C4-I, Me180, and Ms751) and two different HPV-negative (C33A and HT3) cell lines were studied. Long-range restriction mapping using a number of q13-specific probes showed molecular arrangements within 75 kb of INT2 probe in three HPV-positive cell lines (HeLa, SiHa, and Caski) and in an HPV-negative cell line (HT3). FISH using an INT2 YAC identified a breakpoint within the sequences spanned by this YAC in two of the cell lines, HeLa and Caski. INT2 cosmid derived from this YAC showed deletion of cosmid sequences in two other cell lines, SiHa and C33A. These two cell lines, however, retained cosmid sequences of Cyclin D1, a probe localized 100 kb proximal to INT2. Deletions being the hallmark of a tumor-suppressor gene, we conclude that the 100-kb interval between the two cosmids might contain sequences of the cervical carcinoma tumor-suppressor gene. 28 refs., 9 figs.
- OSTI ID:
- 70448
- Journal Information:
- American Journal of Human Genetics, Vol. 56, Issue 3; Other Information: PBD: Mar 1995
- Country of Publication:
- United States
- Language:
- English
Similar Records
Alterations of chromosome 11q13 in cervical carcinoma cell lines
Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells